Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Am J Surg Pathol. 2013 Aug;37(8):1192-200. doi: 10.1097/PAS.0b013e318282649b.
High-level microsatellite instability (MSI-high) is found in approximately 15% of all colorectal adenocarcinomas (CRCs) and in at least 20% of right-sided cancers. It is most commonly due to somatic hypermethylation of the MLH1 gene promoter region, with familial cases (Lynch syndrome) representing only 2% to 3% of CRCs overall. In contrast to CRC, MSI-high in appendiceal adenocarcinomas is rare. Only 4 MSI-high appendiceal carcinomas and 1 MSI-high appendiceal serrated adenoma have been previously reported, and the prevalence of MSI in the appendix is unknown. We identified 108 appendiceal carcinomas from MD Anderson Cancer Center in which MSI status had been assessed by immunohistochemistry for the DNA mismatch-repair proteins MLH1, MSH2, MSH6, and PMS2 (n=83), polymerase chain reaction (n=7), or both (n=18). Three cases (2.8%) were MSI-high, and 1 was MSI-low. The 3 MSI-high cases included: (1) a poorly differentiated nonmucinous adenocarcinoma with loss of MLH1/PMS2 expression, lack of MLH1 promoter methylation, and lack of BRAF gene mutation, but no detected germline mutation in MLH1 from a 39-year-old man; (2) an undifferentiated carcinoma with loss of MSH2/MSH6, but no detected germline mutation in MSH2 or TACSTD1, from a 59-year-old woman; and (3) a moderately differentiated mucinous adenocarcinoma arising in a villous adenoma with loss of MSH2/MSH6 expression, in a 38-year-old man with a strong family history of CRC who declined germline testing. When the overall group of appendiceal carcinomas was classified according to histologic features and precursor lesions, the frequencies of MSI-high were: 3 of 108 (2.8%) invasive carcinomas, 3 of 96 (3.1%) invasive carcinomas that did not arise from a background of goblet cell carcinoid tumors, and 0 of 12 (0%) signet ring and mucinous carcinomas arising in goblet cell carcinoid tumors. These findings, in conjunction with the previously reported MSI-high appendiceal carcinomas, highlight the low prevalence of MSI in the appendix as compared with the right colon and suggest that MLH1 promoter methylation is not a mechanism for MSI in this location.
高水平微卫星不稳定性(MSI-高)存在于约 15%的所有结直肠腺癌(CRC)和至少 20%的右侧癌症中。它最常见于 MLH1 基因启动子区域的体细胞超甲基化,家族病例(林奇综合征)占 CRC 的总体比例仅为 2%至 3%。与 CRC 不同,阑尾腺癌中的 MSI-高很少见。先前仅报道了 4 例 MSI-高阑尾癌和 1 例 MSI-高阑尾锯齿状腺瘤,阑尾中 MSI 的流行情况尚不清楚。我们从 MD 安德森癌症中心鉴定了 108 例阑尾癌,其中 83 例通过免疫组织化学检测 DNA 错配修复蛋白 MLH1、MSH2、MSH6 和 PMS2(n=83)、聚合酶链反应(n=7)或两者(n=18)评估 MSI 状态。3 例(2.8%)为 MSI-高,1 例为 MSI-低。这 3 例 MSI-高病例包括:(1)分化不良的非黏液性腺癌,MLH1/PMS2 表达缺失,MLH1 启动子甲基化缺失,BRAF 基因突变缺失,但来自 39 岁男性的 MLH1 无种系突变;(2)未分化癌,MSH2/MSH6 缺失,但 MSH2 或 TACSTD1 无种系突变,来自 59 岁女性;(3)中度分化黏液性腺癌,起源于绒毛状腺瘤,MSH2/MSH6 表达缺失,38 岁男性家族性 CRC 病史强,拒绝种系检测。当根据组织学特征和前体病变对整个阑尾癌组进行分类时,MSI-高的频率为:108 例浸润性癌中的 3 例(2.8%),96 例浸润性癌中不源于杯状细胞类癌肿瘤背景的 3 例(3.1%),以及 12 例(0%)起源于杯状细胞类癌肿瘤的印戒细胞和黏液性腺癌中无 0 例。这些发现与先前报道的 MSI-高阑尾癌一起,强调了与右结肠相比,阑尾中 MSI 的低发生率,并表明 MLH1 启动子甲基化不是该部位 MSI 的机制。